A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

Scientists have successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Tocilizumab, an anti–IL-6 receptor monoclonal antibody, is typically used to manage CRS, whereas corticosteroids may also be used to suppress the immune reaction. CRS and neurotoxicity occur when ...

Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan International Master Program in ...

This research was supported by National Institutes of Health (NIH) Grant NS 20023 and Grant CA 11898 and by NIH Grant MO1 RR30, General Clinical Research Centers Program, National Center for ...

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee. *Corresponding Author: Brent A. Orr, Department of Pathology, St. Jude Children ...

with then-CEO Richard Gonzalez telling analysts back in 2023 that the BCMA bispecific antibody T-cell engager ABBV-383 was driving the company’s “high level of interest” in the space.

Given that VPA can cross the blood-brain barrier, we investigated the effect of VPA on the expression of surface NKG2D ligands in glioma cell lines and attempted to combine VPA and NKG2D CAR-T to ...

The breakthrough could explain how adult brain cells take advantage of developmental processes to instigate the explosive growth seen in deadly brain cancers like glioblastoma. The researchers made ...